Drug interactions between antiplatelet or novel oral anticoagulant medications and antiretroviral medications
G Egan, CA Hughes… - Annals of …, 2014 - journals.sagepub.com
Objective: To review potential drug interactions between antiretroviral (ARV) medications
and antiplatelets or novel oral anticoagulants (NOACs). Data Sources: A literature search of …
and antiplatelets or novel oral anticoagulants (NOACs). Data Sources: A literature search of …
Validation of the vessel-specific leads (VSLs) for acute ischemia detection on a dataset with non-ischemic ST-segment deviation
JJ Wang, O Pahlm, GS Wagner… - 2015 Computing in …, 2015 - ieeexplore.ieee.org
Existing criteria recommended by ACC/ESC for identifying patients with ST-elevation
myocardial infarction (STEMI) from the 12-lead ECG perform with high specificity (SP), but …
myocardial infarction (STEMI) from the 12-lead ECG perform with high specificity (SP), but …
TRimetazidine as an Agent to affeCt clopidogrEl Response: the TRACER study
N Seecheran, V Seebalack, R Seecheran… - Cardiology and …, 2019 - Springer
Introduction This prospective study aimed to determine whether trimetazidine (TMZ) alters
the pharmacodynamic (PD) effects of clopidogrel. Methods Patients with stable coronary …
the pharmacodynamic (PD) effects of clopidogrel. Methods Patients with stable coronary …
Utjecaj rane primjene statina na klinički ishod u bolesnika s akutnim infarktom miokarda
P Mjehović - 2017 - zir.nsk.hr
Sažetak Kardiovaskularne bolesti su vodeći uzrok smrtnosti u razvijenim zemljama, među
kojima bolest koronarnih arterija ima najveću prevalenciju i povezana je s visokim …
kojima bolest koronarnih arterija ima najveću prevalenciju i povezana je s visokim …